View in EDS

SAT-251 Semaglutide can reduce alcohol use in patients with metabolic dysfunction-associated steatotic liver disease.

Saved in:
Bibliographic Details
Title: SAT-251 Semaglutide can reduce alcohol use in patients with metabolic dysfunction-associated steatotic liver disease.
Authors: Fomin, Vladislav (AUTHOR), Buckholz, Adam (AUTHOR), Liu, Yihan (AUTHOR), Mallick, Himel (AUTHOR), Kumar, Sonal (AUTHOR)
Source: Journal of Hepatology. 2024 Supplement 1, Vol. 80, pS138-S138. 1p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first